BrightPath Biotherapeutics Co Ltd (4594) Stock Price & News

Why is 4594 down 4.08%?

Dive Deeper

4594:TYO

BrightPath Biotherapeutics Co Ltd

¥47.00

-4.08%

(-2.00) 1D

Oct 5, 3:21:32 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4594...

Open

¥48

High

¥49

Low

¥46

Mkt. cap

6.53B

Avg. vol.

1.60M

Volume

1.53M

52-wk high

¥96

52-wk low

¥43

EPS

-¥13

Shares outstanding

41.98M

No. of employees

Open

¥48

High

¥49

Low

¥46

Mkt. cap

6.53B

Avg. vol.

1.60M

Volume

1.53M

52-wk high

¥96

52-wk low

¥43

EPS

-¥13

Shares outstanding

41.98M

No. of employees

Related stocks

4596

Kubota Pharmaceutical Holdings Co Ltd

Oncolys Biopharma Inc

¥6,510.00

+8.86%

2134

Kitahama Capital Partners Co Ltd

¥19.00

+5.56%

News stories

From web sources and news partners

FXLeaders

20 minutes ago

Dow Futures Lifted as Infrastructure & Data Center CapEx Spark Industrial Rally

www.marketscreener.com

47 minutes ago

Panmure Liberum sets 2027 year-end S&P 500 target at 5,000

TradingView

45 minutes ago

IXIC: Nasdaq Futures Flash Green as Traders Double Down on Risk. Rate-Hike Fear Is Fading

MSN

21 hours ago

This rare market signal has appeared only 2 times in a century. Here is what history says comes next.

About BrightPath Biotherapeutics Co Ltd

CEO-

Employees23

FoundedMay 8, 2003

Headquarters-

SectorBiotechnology

Websitebrightpathbio.com

All values in JPY	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	16.50K	16.50K	-	51.00K
Cost of goods sold	4.00K	4.00K	-	21.00K
Cost of revenue	4.00K	4.00K	-	21.00K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	232.30M	232.30M	492.02M	338.44M
Operating expense	232.30M	232.30M	492.02M	338.44M
Total operating expenses	232.30M	232.30M	492.02M	338.46M
Operating income	-232.29M	-232.29M	-492.02M	-338.41M
Other non operating income	2.39M	2.39M	4.27M	-18.95M
EBT including unusual items	-230.76M	-230.76M	-491.75M	-349.25M
EBT excluding unusual items	-230.47M	-230.47M	-491.75M	-358.87M
Income tax expense	605.00K	605.00K	605.00K	605.00K
Effective tax rate	-0.26%	-0.26%	-0.12%	-0.17%
Other operating expenses	-	-	-	-
Net income	-231.37M	-231.37M	-492.36M	-349.86M
Net profit margin	-1,402,233.33%	-1,402,233.33%	-	-685,998.04%
Earnings per share	-	-	-	-
Interest and investment income	6.00K	6.00K	-	4.00K
Interest expense	-	-	-	-
Net interest expenses	6.00K	6.00K	-	4.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything